Thiti Snabboon

427 total citations
31 papers, 295 citations indexed

About

Thiti Snabboon is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Thiti Snabboon has authored 31 papers receiving a total of 295 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Molecular Biology and 6 papers in Surgery. Recurrent topics in Thiti Snabboon's work include Pituitary Gland Disorders and Treatments (6 papers), Diabetes and associated disorders (4 papers) and Growth Hormone and Insulin-like Growth Factors (3 papers). Thiti Snabboon is often cited by papers focused on Pituitary Gland Disorders and Treatments (6 papers), Diabetes and associated disorders (4 papers) and Growth Hormone and Insulin-like Growth Factors (3 papers). Thiti Snabboon collaborates with scholars based in Thailand, Australia and Bulgaria. Thiti Snabboon's co-authors include Vitaya Sridama, Nattiya Hirankarn, Patinut Buranasupkajorn, Thidathip Wongsurawat, Aurauma Chutinet, Suthep Udomsawaengsup, Ingorn Kimkong, Yingyos Avihingsanon, Nijasri C. Suwanwela and Napasri Chaisinanunkul and has published in prestigious journals such as Journal of Alzheimer s Disease, Clinical Endocrinology and QJM.

In The Last Decade

Thiti Snabboon

28 papers receiving 290 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thiti Snabboon Thailand 12 108 83 66 56 55 31 295
Laura C. Kutz United States 6 184 1.7× 102 1.2× 42 0.6× 47 0.8× 36 0.7× 9 367
Sezer Acar Türkiye 9 78 0.7× 94 1.1× 96 1.5× 23 0.4× 76 1.4× 48 366
A. Boumédiène France 9 85 0.8× 100 1.2× 30 0.5× 71 1.3× 25 0.5× 20 467
Judith López‐Fernández Spain 10 169 1.6× 82 1.0× 47 0.7× 17 0.3× 21 0.4× 15 309
P. Mathern United States 10 116 1.1× 132 1.6× 102 1.5× 52 0.9× 16 0.3× 17 437
K.S. Lau Hong Kong 11 105 1.0× 159 1.9× 53 0.8× 39 0.7× 34 0.6× 22 403
Maud Clemessy France 11 115 1.1× 165 2.0× 34 0.5× 19 0.3× 93 1.7× 18 354
Anna Klukovits Hungary 11 69 0.6× 104 1.3× 32 0.5× 32 0.6× 38 0.7× 18 341
Yui Yamashita Japan 9 79 0.7× 67 0.8× 30 0.5× 23 0.4× 34 0.6× 16 328
Margot M. Linssen Netherlands 10 132 1.2× 133 1.6× 90 1.4× 36 0.6× 60 1.1× 18 382

Countries citing papers authored by Thiti Snabboon

Since Specialization
Citations

This map shows the geographic impact of Thiti Snabboon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thiti Snabboon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thiti Snabboon more than expected).

Fields of papers citing papers by Thiti Snabboon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thiti Snabboon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thiti Snabboon. The network helps show where Thiti Snabboon may publish in the future.

Co-authorship network of co-authors of Thiti Snabboon

This figure shows the co-authorship network connecting the top 25 collaborators of Thiti Snabboon. A scholar is included among the top collaborators of Thiti Snabboon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thiti Snabboon. Thiti Snabboon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Plongla, Rongpong, et al.. (2025). Adrenal Histoplasmosis and Tuberculosis: Clinical Presentations and a High Prevalence of Adrenal Insufficiency. Clinical Endocrinology. 103(2). 137–146.
2.
Snabboon, Thiti, et al.. (2024). Assessment of plasma dexamethasone levels after 1‐mg dexamethasone suppression test in adults with obesity. Clinical Endocrinology. 100(4). 332–337. 3 indexed citations
3.
Supasitthumrong, Thitiporn, Chavit Tunvirachaisakul, Thiti Snabboon, et al.. (2020). Lower thiol, glutathione, and glutathione peroxidase levels in prostate cancer: a meta-analysis study. The Aging Male. 23(5). 1533–1544. 11 indexed citations
4.
Chutinet, Aurauma, et al.. (2020). Diabetic Striatopathy. Acta Médica Portuguesa. 34(12). 874–875. 2 indexed citations
5.
Buranasupkajorn, Patinut, et al.. (2019). Hypokalemic Periodic Paralysis as the First Manifestation of Thyrotropin-Secreting Pituitary Adenoma. Case Reports in Endocrinology. 2019. 1–4.
7.
Shuangshoti, Shanop, et al.. (2017). A case of coexistence of TSH/GH-secreting pituitary tumor and papillary thyroid carcinoma: Challenges in pathogenesis and management. Journal of Clinical Neuroscience. 41. 78–80. 8 indexed citations
8.
Udomsawaengsup, Suthep, et al.. (2016). Changes in Testosterone Levels and Sex Hormone-Binding Globulin Levels in Extremely Obese Men after Bariatric Surgery. International Journal of Endocrinology. 2016. 1–5. 31 indexed citations
9.
10.
Jongjaroenprasert, Wallaya, Theerawut Phusantisampan, Surakameth Mahasirimongkol, et al.. (2012). A genome-wide association study identifies novel susceptibility genetic variation for thyrotoxic hypokalemic periodic paralysis. Journal of Human Genetics. 57(5). 301–304. 28 indexed citations
11.
Tongkobpetch, Siraprapa, Verayuth Praphanphoj, Charan Mahatumarat, et al.. (2011). PTPRF is disrupted in a patient with syndromic amastia. BMC Medical Genetics. 12(1). 46–46. 11 indexed citations
12.
Chutinet, Aurauma, Nijasri C. Suwanwela, Thiti Snabboon, et al.. (2011). Association between Genetic Polymorphisms and Sites of Cervicocerebral Artery Atherosclerosis. Journal of Stroke and Cerebrovascular Diseases. 21(5). 379–385. 22 indexed citations
13.
Kimkong, Ingorn, et al.. (2011). Association between CTLA-4 polymorphisms and the susceptibility to systemic lupus erythematosus and Graves' disease in Thai population.. PubMed. 29(3). 229–35. 24 indexed citations
14.
Shuangshoti, Shanop, et al.. (2010). Craniofacial Fibrous Dysplasia. Internal Medicine. 49(3). 249–250. 1 indexed citations
15.
Wattanachanya, Lalita, Udomsak Bunworasate, Wanee Plengpanich, et al.. (2009). Bilateral pheochromocytoma during the postpartum period. Archives of Gynecology and Obstetrics. 280(6). 1055–1058. 12 indexed citations
16.
Rerknimitr, Rungsun, Vorasuk Shotelersuk, Patinut Buranasupkajorn, Wanee Plengpanich, & Thiti Snabboon. (2008). A novel SPINK1 gene mutation, c.206C>T, in a Thai patient with chronic alcoholic pancreatitis.. PubMed. 9(1). 33–6. 5 indexed citations
17.
Wongsurawat, Thidathip, et al.. (2006). Association of TNF-alpha, TNF-beta, IFN-gamma and IL-1Ra gene polymorphisms with Graves' disease in the Thai population.. PubMed. 24(4). 207–11. 15 indexed citations
18.
Snabboon, Thiti, et al.. (2006). A SPINK1 gene mutation in a Thai patient with fibrocalculous pancreatic diabetes.. PubMed. 37(3). 559–62. 5 indexed citations
19.
Wongsurawat, Thidathip, et al.. (2005). The association between HLA class II haplotype with Graves' disease in Thai population. Tissue Antigens. 67(1). 79–83. 28 indexed citations
20.
Phupong, Vorapong, et al.. (2004). Bilateral pheochromocytoma during pregnancy. Archives of Gynecology and Obstetrics. 271(3). 277–280. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026